Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suling Liu

Showing results (111-120 of 146) with videos related to

Pageof 15
Sort By:
Cancer Research|January 13, 2011
Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networksSuling Liu, Christophe Ginestier, Sing J Ou, et al.
Nature Communications|March 17, 2022
Cancer stem cell regulated phenotypic plasticity protects metastasized cancer cells from ferroptosisMingming Wu, Xiao Zhang, Weijie Zhang, et al.
Cell Stem Cell|March 29, 2008
ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcomeChristophe Ginestier, Min Hee Hur, Emmanuelle Charafe-Jauffret, et al.
Signal Transduction and Targeted Therapy|March 1, 2023
PMN-MDSCs modulated by CCL20 from cancer cells promoted breast cancer cell stemness through CXCL2-CXCR2 pathwayRui Zhang, Mengxue Dong, Juchuanli Tu, et al.
Journal for Immunotherapy of Cancer|May 25, 2022
Ccl3 enhances docetaxel chemosensitivity in breast cancer by triggering proinflammatory macrophage polarizationDandan Sheng, Wei Ma, Rui Zhang, et al.
Journal of Infection and Public Health|May 17, 2026
Novel polymyxin-resistant Klebsiella pneumoniae with ten resistance determinants and associated mutations drive localized outbreaksKaixuan Yuan, Jiao Zhang, Yurong Qin, et al.
Cancer Research|September 28, 2021
ALDH1A1 Activity in Tumor-Initiating Cells Remodels Myeloid-Derived Suppressor Cells to Promote Breast Cancer ProgressionCuicui Liu, Jiankun Qiang, Qiaodan Deng, et al.
Nature Communications|July 21, 2021
TEM8 marks neovasculogenic tumor-initiating cells in triple-negative breast cancerJiahui Xu, Xiaoli Yang, Qiaodan Deng, et al.
Plos Biology|July 28, 2018
CCL20 triggered by chemotherapy hinders the therapeutic efficacy of breast cancerWeilong Chen, Yuanyuan Qin, Dong Wang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 12, 2024
SOSTDC1 Nuclear Translocation Facilitates BTIC Maintenance and CHD1-Mediated HR Repair to Promote Tumor Progression and Olaparib Resistance in TNBCQiaodan Deng, Jiankun Qiang, Cuicui Liu, et al.
Pageof 15

Showing results (111-120 of 146) with videos related to

Sort By:
Pageof 15
Cancer Research|January 13, 2011
Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networksSuling Liu, Christophe Ginestier, Sing J Ou, et al.
Nature Communications|March 17, 2022
Cancer stem cell regulated phenotypic plasticity protects metastasized cancer cells from ferroptosisMingming Wu, Xiao Zhang, Weijie Zhang, et al.
Cell Stem Cell|March 29, 2008
ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcomeChristophe Ginestier, Min Hee Hur, Emmanuelle Charafe-Jauffret, et al.
Signal Transduction and Targeted Therapy|March 1, 2023
PMN-MDSCs modulated by CCL20 from cancer cells promoted breast cancer cell stemness through CXCL2-CXCR2 pathwayRui Zhang, Mengxue Dong, Juchuanli Tu, et al.
Journal for Immunotherapy of Cancer|May 25, 2022
Ccl3 enhances docetaxel chemosensitivity in breast cancer by triggering proinflammatory macrophage polarizationDandan Sheng, Wei Ma, Rui Zhang, et al.
Journal of Infection and Public Health|May 17, 2026
Novel polymyxin-resistant Klebsiella pneumoniae with ten resistance determinants and associated mutations drive localized outbreaksKaixuan Yuan, Jiao Zhang, Yurong Qin, et al.
Cancer Research|September 28, 2021
ALDH1A1 Activity in Tumor-Initiating Cells Remodels Myeloid-Derived Suppressor Cells to Promote Breast Cancer ProgressionCuicui Liu, Jiankun Qiang, Qiaodan Deng, et al.
Nature Communications|July 21, 2021
TEM8 marks neovasculogenic tumor-initiating cells in triple-negative breast cancerJiahui Xu, Xiaoli Yang, Qiaodan Deng, et al.
Plos Biology|July 28, 2018
CCL20 triggered by chemotherapy hinders the therapeutic efficacy of breast cancerWeilong Chen, Yuanyuan Qin, Dong Wang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 12, 2024
SOSTDC1 Nuclear Translocation Facilitates BTIC Maintenance and CHD1-Mediated HR Repair to Promote Tumor Progression and Olaparib Resistance in TNBCQiaodan Deng, Jiankun Qiang, Cuicui Liu, et al.
Pageof 15